Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

IACP Presents Issues and Concerns of the Compounding Pharmacist Community Today to FDA

Thursday, April 30, 2015   (0 Comments)
Posted by: Dagmar Anderson
Share |

Today, IACP is participating in Pharmacy Compounding Stakeholder meeting atThe Food & Drug Administration (FDA) White Oak Campus in Silver Spring, Md.

FDA has been holding a series of listening sessions with groups of interested stakeholders to discuss FDA’s efforts to implement the compounding provisions of the Drug Quality and Security Act, signed into law in November, 2013.

 

IACP's Comments

Please click here to read IACP's Issues and Concerns of the Compounding Pharmacist Community submitted for today's session with the FDA.


Association Management Software Powered by YourMembership  ::  Legal